Kinase Inhibitors

Solcitinib (GSK2586184A) View larger

Solcitinib (GSK2586184A)

AOB87636

CAS: 1206163-45-2

 

Chemical Name: GSK2586184A; N-[5-[4-(3,3-Dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide

 

More details

Molarity Calculation Cart®

HOW TO ORDER

$10.00

$10.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $4.50 Total: $450.00
150 $5.20 Total: $260.00
125 $6.10 Total: $152.50
110 $7.20 Total: $72.00
15 $8.50 Total: $42.50

Data sheet

Molecular FormulaC22H23N5O2
Molecular Weight389.45
CAS Numbers1206163-45-2
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymGSK2586184; GSK 2586184; GSK-2586184; GSK2586184A; GSK-2586184A; GSK 2586184A; GLPG-0778; GLPG 0778; GLPG0778; G154578; Solcitinib
IUPAC/Chemical NameN-(5-(4-(3,3-dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
InChl KeyMPYACSQFXVMWNO-UHFFFAOYSA-N
InChl CodeInChI=1S/C22H23N5O2/c1-22(2)12-26(13-22)20(29)16-10-6-14(7-11-16)17-4-3-5-18-23-21(25-27(17)18)24-19(28)15-8-9-15/h3-7,10-11,15H,8-9,12-13H2,1-2H3,(H,24,25,28)
SMILES CodeO=C(C1CC1)NC2=NN3C(C4=CC=C(C(N5CC(C)(C)C5)=O)C=C4)=CC=CC3=N2
ReferencesLudbrook VJ, et al. Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study. Br J Dermatol. 2016 May;174(5):985-95.

More info

Novel signal transduction pathway inhibitor and Janus kinase 1 (JAK1) inhibitor